Market Cap

Q BioMed, Inc. Market Capitalization:

$435,285

USD as of July 1, 2023

business Q BioMed, Inc. Company Profile

Q BioMed, Inc. Main Stock Listing

OTC: QBIO

Market Capitalization History of Q BioMed, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Q BioMed, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $632,862 -98.14%
Jan. 1, 2022 $34.0 M -51.60%
Jan. 1, 2021 $70.3 M -54.55%
Jan. 1, 2020 $154.7 M 6.28%
Jan. 1, 2019 $145.6 M -47.59%
Jan. 1, 2018 $277.8 M -16.84%
Jan. 1, 2017 $334.0 M 25.00%
Jan. 1, 2016 $267.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +181.22%

$10,000 in June 2023 would now be $28,122 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Q BioMed, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Q BioMed, Inc. has the following listings and related stock indices.


Stock: OTC: QBIO

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.